(Press-News.org) Results from an observational study evaluating a new anti-TB drug have found that the treatment can improve outcomes and reduce mortality among patients with both MDR-TB and XDR-TB.
The research, published online ahead of print today (27 September 2012) in the European Respiratory Journal, suggests a drug called delamanid could have a public health benefit for MDR-TB and also for XDR-TB, as few effective treatment options are currently available.
Over the past two decades, multidrug-resistant TB (MDR-TB) has emerged as a significant public health threat, with strains of TB growing increasingly resistant to first-line drugs. MDR-TB hampers progress towards the global elimination of TB and recently it has further evolved into an even more resistant form, called extensively drug-resistant tuberculosis (XDR-TB).
The WHO Global Plan to Stop TB 2011-2015 has called for urgent development of new drugs with novel mechanisms of action to treat all forms of TB, including MDR and XDR-TB.
A randomised control trial has previously evaluated the effectiveness of 2 months treatment with different doses of the drug. The new study followed the same patients and observed the outcomes of their treatment for a further 24 months.
421 patients took part in the observational study and researchers examined the effects of delamanid when taken in combination with a World Health Organization-recommended background treatment regimen. The researchers classified the patients into either a favourable outcomes group, where the patient was cured or completed the treatment, or an unfavourable outcome, where the patient had failed the treatment course, defaulted or died.
The results found that 74.5% of patients taking delamanid for more than 6 months had favourable outcomes. This compared to 55% of patients taking the drug for less than 2 months. Furthermore, only two patient deaths occurred in the long-term group, compared to 19 in the short-term treatment group.
In the subset of patients suffering with XDR-TB, 61.4% of patients in the long-term group experienced favourable outcomes, compared with 50% in the short-term group. Mortality was also reduced within this subset.
Lead author, Vija Skripconoka from the Riga East University Hospital, said: "The observational study has shown that when delamanid is taken for at least 6 months with a WHO-recommended background treatment regimen, it can improve outcomes for patients with MDR-TB and XDR-TB. This is extremely positive news given that similar studies of different treatments rarely report favourable outcomes above 70% or mortality rates below 15%. The 1% mortality rate measured in this study is very promising. A further randomised-control study is currently enrolling a large group of people to confirm delamanid's effectiveness and monitor side-effects."
### END
TB drug could reduce mortality for MDR-TB and XDR-TB cases
2012-09-27
ELSE PRESS RELEASES FROM THIS DATE:
Salt marsh carbon may play role in slowing climate warming, study shows
2012-09-27
A warming climate and rising seas will enable salt marshes to more rapidly capture and remove carbon dioxide from the atmosphere, possibly playing a role in slowing the rate of climate change, according to a new study led by a University of Virginia environmental scientist and published in the Sept. 27 issue of the journal Nature.
Carbon dioxide is the predominant so-called "greenhouse gas" that acts as sort of an atmospheric blanket, trapping the Earth's heat. Over time, an abundance of carbon dioxide can change the global climate, according to generally accepted scientific ...
WSU study finds dioxin causes disease and reproductive problems across generations
2012-09-27
PULLMAN, Wash.—Since the 1960s, when the defoliant Agent Orange was widely used in Vietnam, military, industry and environmental groups have debated the toxicity of its main ingredient, the chemical dioxin, and how it should be regulated.
But even if all the dioxin were eliminated from the planet, Washington State University researchers say its legacy will live on in the way it turns genes on and off in the descendants of people exposed over the past half century.
Writing in the journal PLoS ONE, biologist Michael Skinner and members of his lab say dioxin administered ...
Inadequate cellular rest may explain effects of aging on muscles
2012-09-27
Is aging inevitable? What factors make older tissues in the human body less able to maintain and repair themselves, as in the weakening and shrinkage of aging muscles in humans? A new study from Massachusetts General Hospital (MGH) investigators and collaborators at King's College London describes the mechanism behind impaired muscle repair during aging and a strategy that may help rejuvenate aging tissue by manipulating the environment in which muscle stem cells reside. The report will appear in the journal Nature and has received advance online release.
Rare muscle ...
Gut bacteria could cause diabetes
2012-09-27
VIDEO:
Studying gut bacteria can reveal a range of human illness. Now, new research shows that the composition of a person’s intestinal bacteria could play an important role in the development...
Click here for more information.
The number of people suffering from type 2 diabetes world-wide has risen rapidly in recent years, and scientists estimate that just as many people could be suffering from the illness without realising it. New research now indicates that your gut bacteria ...
New AACAP Practice Parameter on gay, lesbian, bisexual, and gender variant issues
2012-09-27
Washington D.C., September 26, 2012 – The American Academy of Child and Adolescent Psychiatry (AACAP) is proud to announce its new Practice Parameter on issues related to and affecting gay, lesbian, bisexual, and gender variant youth.
Gay, lesbian, bisexual, and gender variant children and adolescents face unique developmental challenges and stressors that can influence their mental health and wellbeing. Social issues such as stigma, bullying, and discrimination, and personal factors like internalized prejudice and feelings of being different are just a few of the concerns ...
BGI presents a metagenome-wide association study of gut microbiota in type 2 diabetes
2012-09-27
September 26, 2012, Shenzhen, China – BGI announces the online publication in the international journal Nature of a novel metagenomic study on human gut microbiota and their potential impact on type 2 diabetes (T2D), the most common form of diabetes. This work lays an important foundation for comprehensively understanding the genetic characteristics of gut microbiota and their relationship to T2D risk, as well as providing a new way of classifying microbes detected by DNA sequence. The work here also opens the way for transferring the potential value of a gut-microbiota-based ...
UF biologist discovers mammal with salamander-like regenerative abilities
2012-09-27
GAINESVILLE, Fla. --- A small African mammal with an unusual ability to regrow damaged tissues could inspire new research in regenerative medicine, a University of Florida study finds.
For years biologists have studied salamanders for their ability to regrow lost limbs. But amphibian biology is very different than human biology, so lessons learned in laboratories from salamanders are difficult to translate into medical therapies for humans. New research in the Sept. 27 issue of the journal Nature describes a mammal that can regrow new body tissues following an injury. ...
MBARI researchers discover what vampire squids eat
2012-09-27
MOSS LANDING, CA — About 100 years ago, marine biologists hauled the first vampire squid up from the depths of the sea. Since that time, perhaps a dozen scientific papers have been published on this mysterious animal, but no one has been able to figure out exactly what it eats. A new paper by MBARI Postdoctoral Fellow Henk-Jan Hoving and Senior Scientist Bruce Robison shows for the first time that, unlike its relatives the octopuses and squids, which eat live prey, the vampire squid uses two thread-like filaments to capture bits of organic debris that sink down from the ...
Making the healthy choice
2012-09-27
PASADENA, Calif.—Almost everyone knows the feeling: you see a delicious piece of chocolate cake on the table, but as you grab your fork, you think twice. The cake is too fattening and unhealthy, you tell yourself. Maybe you should skip dessert.
But the cake still beckons.
In order to make the healthy choice, we often have to engage in this kind of internal struggle. Now, scientists at the California Institute of Technology (Caltech) have identified the neural processes at work during such self-regulation—and what determines whether you eat the cake.
"We seem to ...
Researchers determine how inflammatory cells function, setting stage for future remedies
2012-09-27
A research team led by investigators at New York University and NYU School of Medicine has determined how cells that cause inflammatory ailments, such as Crohn's disease, multiple sclerosis, and arthritis, differentiate from stem cells and ultimately affect the clinical outcome of these diseases.
"We've found that hundreds of new genes are involved in the function and development of these cells," said co-author Richard Bonneau, an associate professor at New York University's Center for Genomics and Systems Biology and the Courant Institute of Mathematical Sciences. "This ...